Recombinant Human EHBP1 Protein, N-His from ProteoGenix; catalogue ARO-P12066; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human EHBP1 Protein is a type of protein that is produced through genetic engineering techniques. It is a highly purified and bioactive protein that has a wide range of applications in the field of biotechnology and medicine. In this article, we will explore the structure, activity, and applications of Recombinant Human EHBP1 Protein in detail.
Recombinant Human EHBP1 Protein is a 170 kDa protein that is composed of 1488 amino acids. It is a member of the EH domain-containing protein family and is highly conserved among different species. The protein is composed of multiple domains, including an N-terminal EH domain, a central coiled-coil domain, and a C-terminal proline-rich domain. These domains are important for the protein’s function and interaction with other molecules.
The EH domain is responsible for the protein’s binding to other proteins and is involved in protein-protein interactions. It is composed of three alpha-helices and a beta-sheet, and it forms a compact structure. The EH domain of Recombinant Human EHBP1 Protein has been shown to interact with proteins involved in endocytosis and intracellular trafficking.
The coiled-coil domain is a long, rod-like structure that is formed by two or more alpha-helices coiled around each other. This domain is involved in protein-protein interactions and is important for the stability and function of Recombinant Human EHBP1 Protein. It has been shown to interact with proteins involved in vesicle trafficking and cytoskeletal organization.
The proline-rich domain of Recombinant Human EHBP1 Protein is composed of multiple proline residues and is involved in protein-protein interactions. It has been shown to interact with proteins involved in cell signaling and cytoskeletal organization.
Recombinant Human EHBP1 Protein has been shown to have multiple activities in different cellular processes. It is primarily involved in endocytosis and intracellular trafficking, and it plays a crucial role in maintaining the balance of cellular components. The protein has been shown to interact with various proteins involved in these processes, including Eps15, Epsin, and EHD1.
Moreover, Recombinant Human EHBP1 Protein has been shown to play a role in cell signaling by interacting with proteins involved in the regulation of cell growth and proliferation. It has also been shown to regulate the activity of Rho GTPases, which are important for cell migration and adhesion.
Recombinant Human EHBP1 Protein has a wide range of applications in the field of biotechnology and medicine. Its ability to interact with various proteins involved in endocytosis and intracellular trafficking makes it a valuable tool for studying these processes. It can also be used to study the role of Rho GTPases in cell signaling and cell migration.
Moreover, Recombinant Human EHBP1 Protein has potential therapeutic applications. It has been shown to have anti-tumor activity and can inhibit the growth and proliferation of cancer cells. It has also been shown to play a role in the development of neurological disorders, making it a potential target for drug development.
Recombinant Human EHBP1 Protein can also be used as an antigen for detection in diagnostic assays. Its highly specific interactions with other proteins make it a valuable tool for detecting the presence of specific antibodies in patient samples. This can be useful in the diagnosis of autoimmune diseases and infectious diseases.
The specific interactions of Recombinant Human EHBP1 Protein with other proteins make it a potential drug target. By targeting this protein, it is possible to modulate its activity and potentially treat diseases that involve dysregulation
ProteoGenix catalogue number ARO-P12066. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 14.55 kDa; Fragment: Met1-Asn104; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
